Literature DB >> 19001259

Are Parkinson disease patients protected from some but not all cancers?

Audrey J Strongosky, Matthew Farrer, Zbigniew K Wszolek.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 19001259     DOI： 10.1212/01.wnl.0000339367.54460.8c

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  8 in total

1.  Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls.

Authors:  Ilir Agalliu; Roberto A Ortega; Marta San Luciano; Anat Mirelman; Claustre Pont-Sunyer; Kathrin Brockmann; Dolores Vilas; Eduardo Tolosa; Daniela Berg; Bjørg Warø; Amanda Glickman; Deborah Raymond; Rivka Inzelberg; Javier Ruiz-Martinez; Elisabet Mondragon; Eitan Friedman; Sharon Hassin-Baer; Roy N Alcalay; Helen Mejia-Santana; Jan Aasly; Tatiana Foroud; Karen Marder; Nir Giladi; Susan Bressman; Rachel Saunders-Pullman
Journal:  Mov Disord       Date:  2019-07-26       Impact factor: 10.338

2.  Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis.

Authors:  Ilir Agalliu; Marta San Luciano; Anat Mirelman; Nir Giladi; Bjorg Waro; Jan Aasly; Rivka Inzelberg; Sharon Hassin-Baer; Eitan Friedman; Javier Ruiz-Martinez; Jose Felix Marti-Masso; Avi Orr-Urtreger; Susan Bressman; Rachel Saunders-Pullman
Journal:  JAMA Neurol       Date:  2015-01       Impact factor: 18.302

3.  LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson disease.

Authors:  Rachel Saunders-Pullman; Matthew J Barrett; Kaili M Stanley; Marta San Luciano; Vicki Shanker; Lawrence Severt; Ann Hunt; Deborah Raymond; Laurie J Ozelius; Susan B Bressman
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

Review 4.  The particular relationship between Parkinson's disease and malignancy: a focus on skin cancers.

Authors:  Rivka Inzelberg; Simon D Israeli-Korn
Journal:  J Neural Transm (Vienna)       Date:  2009-11       Impact factor: 3.575

5.  Cancer in Parkinson's disease.

Authors:  Pawel Tacik; Sadie Curry; Shinsuke Fujioka; Audrey Strongosky; Ryan J Uitti; Jay A van Gerpen; Nancy N Diehl; Michael G Heckman; Zbigniew K Wszolek
Journal:  Parkinsonism Relat Disord       Date:  2016-06-20       Impact factor: 4.891

Review 6.  Cancer and neurodegeneration: between the devil and the deep blue sea.

Authors:  Hélène Plun-Favreau; Patrick A Lewis; John Hardy; L Miguel Martins; Nicholas W Wood
Journal:  PLoS Genet       Date:  2010-12-23       Impact factor: 5.917

7.  LRRK2 inhibition potentiates PARP inhibitor cytotoxicity through inhibiting homologous recombination-mediated DNA double strand break repair.

Authors:  Lifeng Chen; Jing Hou; Xiangyu Zeng; Qiang Guo; Min Deng; Jake A Kloeber; Xinyi Tu; Fei Zhao; Zheming Wu; Jinzhou Huang; Kuntian Luo; Wootae Kim; Zhenkun Lou
Journal:  Clin Transl Med       Date:  2021-03

8.  Statistical method on nonrandom clustering with application to somatic mutations in cancer.

Authors:  Jingjing Ye; Adam Pavlicek; Elizabeth A Lunney; Paul A Rejto; Chi-Hse Teng
Journal:  BMC Bioinformatics       Date:  2010-01-07       Impact factor: 3.169
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.